Positive Phase I results for solid dose prescription CBD medicine
Drug Discovery World
DECEMBER 22, 2023
The trial met all pharmacokinetic objectives, so the company plans to progress the candidate into further clinical development and will meet with the US Food and Drug Administration (FDA) at a Pre-IND meeting in the first half of 2024. We now look forward to the next stage of clinical development.”
Let's personalize your content